Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
BP | GO:0042310 | vasoconstriction | 59/11077 | 76/18670 | 0.0005916 | 0.007761 | 0.005584 | 59 | RABC134 | |
BP | GO:0072088 | nephron epithelium morphogenesis | 59/11077 | 76/18670 | 0.0005916 | 0.007761 | 0.005584 | 59 | RABC134 | |
BP | GO:0006939 | smooth muscle contraction | 82/11077 | 110/18670 | 0.000592 | 0.007761 | 0.005584 | 82 | RABC134 | |
BP | GO:0002244 | hematopoietic progenitor cell differentiation | 119/11077 | 166/18670 | 0.0006014 | 0.007867 | 0.005661 | 119 | RABC134 | |
BP | GO:0007588 | excretion | 50/11077 | 63/18670 | 0.0006114 | 0.007983 | 0.005745 | 50 | RABC134 | |
BP | GO:0006968 | cellular defense response | 43/11077 | 53/18670 | 0.0006185 | 0.008011 | 0.005764 | 43 | RABC134 | |
BP | GO:0010043 | response to zinc ion | 43/11077 | 53/18670 | 0.0006185 | 0.008011 | 0.005764 | 43 | RABC134 | |
BP | GO:0045214 | sarcomere organization | 43/11077 | 53/18670 | 0.0006185 | 0.008011 | 0.005764 | 43 | RABC134 | |
BP | GO:1901185 | negative regulation of ERBB signaling pathway | 43/11077 | 53/18670 | 0.0006185 | 0.008011 | 0.005764 | 43 | RABC134 | |
BP | GO:0032872 | regulation of stress-activated MAPK cascade | 165/11077 | 237/18670 | 0.0006233 | 0.008056 | 0.005797 | 165 | RABC134 | |
BP | GO:0008016 | regulation of heart contraction | 174/11077 | 251/18670 | 0.000625 | 0.008062 | 0.005801 | 174 | RABC134 | |
BP | GO:1903305 | regulation of regulated secretory pathway | 115/11077 | 160/18670 | 0.0006266 | 0.008067 | 0.005804 | 115 | RABC134 | |
BP | GO:0032692 | negative regulation of interleukin-1 production | 33/11077 | 39/18670 | 0.0006362 | 0.008142 | 0.005859 | 33 | RABC134 | |
BP | GO:0048713 | regulation of oligodendrocyte differentiation | 33/11077 | 39/18670 | 0.0006362 | 0.008142 | 0.005859 | 33 | RABC134 | |
BP | GO:2000826 | regulation of heart morphogenesis | 33/11077 | 39/18670 | 0.0006362 | 0.008142 | 0.005859 | 33 | RABC134 | |
BP | GO:0045765 | regulation of angiogenesis | 258/11077 | 383/18670 | 0.0006479 | 0.008276 | 0.005955 | 258 | RABC134 | |
BP | GO:0071241 | cellular response to inorganic substance | 152/11077 | 217/18670 | 0.0006541 | 0.008339 | 0.006 | 152 | RABC134 | |
BP | GO:1904888 | cranial skeletal system development | 52/11077 | 66/18670 | 0.0006602 | 0.0084 | 0.006044 | 52 | RABC134 | |
BP | GO:0007517 | muscle organ development | 275/11077 | 410/18670 | 0.0006621 | 0.008407 | 0.006049 | 275 | RABC134 | |
BP | GO:0035148 | tube formation | 107/11077 | 148/18670 | 0.0006741 | 0.008516 | 0.006128 | 107 | RABC134 | |
BP | GO:0061041 | regulation of wound healing | 107/11077 | 148/18670 | 0.0006741 | 0.008516 | 0.006128 | 107 | RABC134 | |
BP | GO:0015893 | drug transport | 150/11077 | 214/18670 | 0.0006746 | 0.008516 | 0.006128 | 150 | RABC134 | |
BP | GO:0006865 | amino acid transport | 105/11077 | 145/18670 | 0.0006851 | 0.008557 | 0.006158 | 105 | RABC134 | |
BP | GO:0070098 | chemokine-mediated signaling pathway | 67/11077 | 88/18670 | 0.0006864 | 0.008557 | 0.006158 | 67 | RABC134 | |
BP | GO:0002076 | osteoblast development | 18/11077 | 19/18670 | 0.0006872 | 0.008557 | 0.006158 | 18 | RABC134 | |
BP | GO:0045063 | T-helper 1 cell differentiation | 18/11077 | 19/18670 | 0.0006872 | 0.008557 | 0.006158 | 18 | RABC134 | |
BP | GO:0046641 | positive regulation of alpha-beta T cell proliferation | 18/11077 | 19/18670 | 0.0006872 | 0.008557 | 0.006158 | 18 | RABC134 | |
BP | GO:0098581 | detection of external biotic stimulus | 18/11077 | 19/18670 | 0.0006872 | 0.008557 | 0.006158 | 18 | RABC134 | |
BP | GO:1905939 | regulation of gonad development | 18/11077 | 19/18670 | 0.0006872 | 0.008557 | 0.006158 | 18 | RABC134 | |
BP | GO:0007187 | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 177/11077 | 256/18670 | 0.0006891 | 0.008565 | 0.006163 | 177 | RABC134 |